Angiogenesis blockade as a new therapeutic approach to experimental colitis. - Wikidata - wikimedia - TriplyDB

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

http://www.wikidata.org/entity/Q35953816

about

Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis Matrix metalloproteinases in inflammatory bowel disease: an update Up-regulation of intestinal vascular endothelial growth factor by Afa/Dr diffusely adhering Escherichia coli Endogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's disease Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC).ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamics Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease.Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis.Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.Role of the endothelium in inflammatory bowel diseases.Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.Anti inflammatory and anti angiogenic effect of black raspberry extract on human esophageal and intestinal microvascular endothelial cells.Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function?Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.Immunopathogenesis of IBD: current state of the art.Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis.The role of thrombospondin 1 on intestinal inflammation and carcinogenesis MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn's disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis.Nilotinib-mediated mucosal healing in a rat model of colitis.VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy.The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8.Extraluminal factors contributing to inflammatory bowel disease Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease.Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases.Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease.Poly-γ-glutamic acid attenuates angiogenesis and inflammation in experimental colitis.Thrombospondin and VEGF-R: is there a correlation in inflammatory bowel disease?FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities.Technical Advance: Function and efficacy of an {alpha}4-integrin antagonist using bioluminescence imaging to detect leukocyte trafficking in murine experimental colitis.Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition.MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury.Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury.Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39.Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions.COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis model.Inhibition of endothelial Slit2/Robo1 signaling by thalidomide restrains angiogenesis by blocking the PI3K/Akt pathway.

P2860

Q24656280-A65D949C-A1CD-48BB-85FC-7760210C1B5C Q28080664-72D16C4B-89B5-4B7A-84D8-3D8EB5B7DF3F Q33312378-D9B9B769-F10D-4A13-ADCE-F326114F0AE4 Q33618488-5051D84C-1866-4BD3-A3B7-AF0485DF1742 Q33655628-7C094446-04DA-423D-BAF7-048ED7E22111 Q33762815-B1D1D0F0-0FFE-4530-8450-2DD8E27A9D41 Q33831778-74BA1724-8402-4BE8-B2CE-3AD80E1DBE2C Q33905709-0E7E9C9A-1D83-40B4-98AB-8FBA7AC8CF79 Q33915046-1FF50028-BF10-4908-AC3C-CB3E7F66CCF7 Q34103283-D2DE8650-FF49-48D9-BAC2-CDA756373221 Q34117538-3E14E285-BA13-439D-AA00-9AEA2AEBF1F6 Q34518038-F4261F69-39AF-4555-BBAF-1DAD01BCC415 Q34579746-1E05C770-EE93-4202-B3D1-877C7617391E Q34723329-C7658D6C-BD08-43A8-BCA6-4AFF04ECD878 Q34765589-65AFFEB6-BA6A-4E16-B5FB-69EBD8FF73D6 Q34876266-E3D69416-9344-487B-80DC-5598C107EAD1 Q35624894-F40FEB64-19C4-4053-AAA8-C65342510A41 Q35719490-22110B96-BD63-47A1-B60A-23F7542E06F5 Q35857951-1843707B-474C-4E13-830E-1AB234B3914F Q36793577-748C4192-CDCF-43C1-B021-F0D9F15326EE Q37010223-83CA21FC-D2D6-48EB-88F4-B09248233959 Q37017694-B547DD10-DE38-4035-8BC6-C649850BC143 Q37208138-01A196D3-D294-4896-B4A0-0FC273569226 Q37359869-3F2A514B-05FB-426D-92B9-20503FEBB03E Q37421164-70D68856-5E46-4791-974D-933676455DDD Q37847061-690BFF90-5E1D-4D88-A333-DC377A69D763 Q38946679-90CADF47-1BE6-4C5E-9F60-B9EE2DE5FCF6 Q39335943-B2794AF7-0B79-4FEA-A1B8-4301876A357B Q39543850-2AC56418-632D-4E75-ABB5-22FE3F74A97D Q41473406-587030AF-53A9-4A77-B47C-8F3C667AB8F2 Q41857388-19DA42F9-5941-4463-A9E3-5E8DAA7FF683 Q41976143-7CC9CE3F-8237-41FB-BC2B-5DF6FDF98FC6 Q42925730-06995BD0-5C14-48B4-B315-66AA6E9BC887 Q43072872-E9DD7782-260F-4FDF-A201-C8A5FEADCF2B Q43117122-77B4CB5D-FABC-4324-A31F-012C4B02742B Q43168068-4BA71B21-3320-47A7-AAB1-A40E48AC5C21 Q46202324-56D2AD7A-99DC-4586-8B7E-C1ABE8CCEE7C Q50129416-6BF1F66C-F70B-4B55-ADA0-F228503B7FCC Q51730548-BE05962F-93D5-476A-8592-FF970A61B84F Q54314849-038B0EC9-0150-4B34-B0BA-D2579DDA07E4

P2860

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

http://www.wikidata.org/entity/Q35953816

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

@ast

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

@en

type

label

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

@ast

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

@en

prefLabel

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

@ast

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

@en

P1433

Q35953816-C747B870-C7D3-4718-AA12-B06AD724F107

P1476

Q35953816-7831048B-6BEE-40DE-BE3F-72CE0BBB88EE

P2093

Q35953816-146C6EB0-ED7E-49EF-897D-526CCD38065D

Q35953816-24F98317-618B-4A8A-A4FE-D7340F9E07EA

Q35953816-3AA482A4-74AB-4FE3-85A7-3074AD87AB4F

Q35953816-536819D9-07F5-431A-A338-AAEEBD3D2D1A

Q35953816-544631D0-998F-4D41-A682-60E9C6F924A7

Q35953816-5B9237E9-5ABF-47AB-9A11-615E901F14E9

Q35953816-73B0B427-0FAA-4762-ABDF-13B9FCCDE60B

Q35953816-8A516EA7-0A32-48B6-AEF8-81066C451114

Q35953816-8DDB7D49-7EE0-43C1-A444-1330364594D1

Q35953816-BED765D9-6330-422F-B5B2-8553092D0243

P2860

Q35953816-01369897-27C8-4BA0-8565-887DC194D050

Q35953816-063A9AEB-97AD-43D5-9429-600D222DDA14

Q35953816-08229838-77B8-45E7-BA37-991279E90F90

Q35953816-089F10A8-C58B-42FF-BD08-F108C0DCD39C

Q35953816-1A2A1BFD-E924-46E3-9B0C-BB1180340DA6

Q35953816-1A8C0C04-A70A-4A5D-BC91-28DB01A6B4BE

Q35953816-1CFF1AFE-FB59-4FB8-9F10-01F610981ED0

Q35953816-2281B7D0-AD9F-4D7A-831A-ED535F093CEC

Q35953816-28F2B639-CCB5-4418-826C-8DCEE3C1B088

Q35953816-3AAB3EAB-3354-4DAA-A0A4-67B4E478D227

P304

Q35953816-01F81E48-59E5-4EFA-80CE-E3801E94FA9E

P31

Q35953816-BB59CE1B-371E-4387-A188-4531763DAAC4

P356

Q35953816-FA03469B-C6E2-4A2B-963E-6B9AEABD6165

P407

Q35953816-3DD728FE-BBAC-4833-8FFC-3E0A18E83136

P433

Q35953816-92C3BADF-DC68-47E5-9F14-2E5E2560122F

P478

Q35953816-F5832B2B-435C-447B-B214-319BE6983D1F

P577

Q35953816-0177BD2C-F8D3-4DDC-B5E9-A9B526988359

P5875

Q35953816-02468541-4126-4B3A-A6CD-15462825E38E

P698

Q35953816-8BC2846D-3286-4E71-B822-F63D026E640B

P932

Q35953816-A197034D-E4DB-4681-95ED-C394A08C0BEE

P356

GUT.2006.114314

P1433

P1476

Angiogenesis blockade as a new therapeutic approach to experimental colitis.

@en

P2093

Alan D Levine

http://www.w3.org/2001/XMLSchema#string

Andrew P Mazar

http://www.w3.org/2001/XMLSchema#string

Carol de la Motte

http://www.w3.org/2001/XMLSchema#string

Claudio Fiocchi

http://www.w3.org/2001/XMLSchema#string

David E Shaw

http://www.w3.org/2001/XMLSchema#string

David M Spencer

http://www.w3.org/2001/XMLSchema#string

Fernando Doñate

http://www.w3.org/2001/XMLSchema#string

Ivy Beck

http://www.w3.org/2001/XMLSchema#string

Marian L Plunkett

http://www.w3.org/2001/XMLSchema#string

Miquel Sans

http://www.w3.org/2001/XMLSchema#string

P2860

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study

Angiogenesis in the pathogenesis of inflammatory joint and lung diseases

Tumor angiogenesis: therapeutic implications

Alpha 5 beta 1 integrin activates an NF-kappa B-dependent program of gene expression important for angiogenesis and inflammation.

Angiogenesis in cancer, vascular, rheumatoid and other disease

Angiogenesis in health and disease

Mechanisms of angiogenesis and arteriogenesis

Requirement of vascular integrin alpha v beta 3 for angiogenesis

In vivo detection of morphological and microvascular changes of the colon in association with colitis using fiberoptic confocal imaging (FOCI).

Imaging of angiogenesis: from microscope to clinic.

P304

855-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2006.114314

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6630073

http://www.w3.org/2001/XMLSchema#string

P698

17170016

http://www.w3.org/2001/XMLSchema#string

P932

1954843

http://www.w3.org/2001/XMLSchema#string